Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3040228 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL30052986 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL3030885 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL28390578 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL8811513 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL30909503 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL8813040 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL3031777 | 0.98 | LMNA (0.39) | LMNARARBALDH1A1HIF1AEPAS1 | |
| SCHEMBL93213 | 0.93 | — | — | |
| Benzene SCHEMBL28158350 | 0.92 | RARB (0.38) | LMNARARBALDH1A1HIF1AEPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100216736-A2 | 2'-CYANOPYRIMIDINE NUCLEOSIDE COMPOUND | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-1371646-B1 | ARYL-SUBSTITUTED ALICYCLIC COMPOUND AND MEDICAL COMPOSITION COMPRISING THE SAME | DAINIPPON SUMITOMO PHARMA CO (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-20100056466-A1 | 2'-Cyanopyrimidine Nucleoside Compound | MATSUDA, AKIRA (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2045256-A1 | 2'-CYANOPYRIMIDINE NUCLEOSIDE COMPOUND | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-7176199-B2 | Aryl-substituted alicyclic compound and medical composition comprising the same | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20040106622-A1 | Aryl-substituted alicylic compound and medical composition comprising the same | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
| EP-1371646-A1 | ARYL-SUBSTITUTED ALICYCLIC COMPOUND AND MEDICAL COMPOSITION COMPRISING THE SAME | Dainippon Pharmaceutical Co., Ltd. (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-5741816-A | CARNITINE COMPOUND | TANABE SEIYAKU CO., LTD. (JP) | 1998-04-21 | — | — | US | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| US-5661106-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-26 | — | — | US | disclosed |
| US-5185027-A | Salicylaldehyde derivatives and salicyclic acid derivatives and their sulfur analogs, and their use as herbicides and bioregulators | BASF AKTIENGESELLSCHAFT (DE) | 1993-02-09 | — | — | US | disclosed |
| EP-0490224-A2 | Derivatives of salicylic aldehyde and salicylic acid, sulfphuranalogs thereof, process and intermediates for their preparation | BASF Aktiengesellschaft (DE) | 1992-06-17 | — | — | EP | disclosed |
| EP-0490060-A1 | Salicylic acid derivatives | BASF Aktiengesellschaft (DE) | 1992-06-17 | — | — | EP | disclosed |
| EP-0479055-A1 | Benzaldoximether derivatives | BASF Aktiengesellschaft (DE) | 1992-04-08 | — | — | EP | disclosed |
| US-5100458-A | Pyrimidine substituted, plant growth regulators | BASF AKTIENGESELLSCHAFT (DE) | 1992-03-31 | — | — | US | disclosed |
| US-5085686-A | Plant growth regulator | BASF AKTIENGESELLSCHAFT (DE) | 1992-02-04 | — | — | US | disclosed |
| US-5057143-A | Herbicides, plant growth regulators | BASF AKTIENGESELLSCHAFT (DE) | 1991-10-15 | — | — | US | disclosed |
| EP-0435104-A2 | Salicylic acid derivatives, process for their preparation and their use as herbicide and bioregulators | BASF Aktiengesellschaft (DE) | 1991-07-03 | — | — | EP | disclosed |
| EP-0402751-A1 | Derivatives of salicylic aldehyde and salicylic acid and sulphur analoges thereof, methodes for preparing them and their use as herbicides and bioregulators | BASF Aktiengesellschaft (DE) | 1990-12-19 | — | — | EP | disclosed |
| EP-0346789-A2 | Salicylic-acid derivatives and their sulfur analogues | BASF Aktiengesellschaft (DE) | 1989-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216736-A2 | 2'-CYANOPYRIMIDINE NUCLEOSIDE COMPOUND | NUDT1, DPYD, SLC29A1 | LMNA 1804/4885RARB 3409/4885ALDH1A1 1284/4885 |
| US-20100056466-A1 | 2'-Cyanopyrimidine Nucleoside Compound | NUDT1, DPYD, SLC29A1 | LMNA 1804/4885RARB 3409/4885ALDH1A1 1284/4885 |
| US-20040106622-A1 | Aryl-substituted alicylic compound and medical composition comprising the same | ITGB3, ITGB1, ITGAL | LMNA 1345/4885RARB 844/4885ALDH1A1 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.